The population of NIH-owned or NIH-supported captive research chimpanzees is quickly becoming aged, and the 1998 NIH breeding moratorium has resulted in a skewed age distribution. As such, behavioral management programs aimed at refining the care of an aging captive chimpanzee population
have become increasingly important. However, little research exists that addresses the ways in which captive chimpanzee behavior differs as a function of the interaction of age and aspects of the captive environment. We examined overall differences in behavior between elderly (35 y and older)
and nonelderly (younger than 35 y) captive chimpanzees. Elderly chimpanzees exhibited significantly more rough scratching (a behavioral indicator of anxiety) and inactivity, less behavioral diversity, and less affiliation than their nonelderly counterparts. We also assessed whether elderly
chimpanzee behavior and wounding rates differed as a function of housing in geriatric (group average age, 35 y or older) or nongeriatric (group average age, younger than 35 y) groups. In our program, geriatric social groups were characterized by smaller group size, more females within the
group, and higher levels of individual mobility impairment compared with nongeriatric groups. Furthermore, elderly chimpanzees housed in geriatric groups displayed significantly increased rough scratching, decreased locomotion and submission than nongeriatric animals but no difference in wounding.
These findings suggest that housing elderly chimpanzees in nongeriatric groups may be beneficial, given that doing so may stimulate locomotion. However, the establishment and maintenance of geriatric groups may be unavoidable as the demographics of the population of captive former research
chimpanzees continues to age. Therefore, refinements to captive geriatric care strategies for chimpanzees should focus on methods of evaluating and enhancing functionally appropriate captive environments within geriatric groups.
Refinements to captive chimpanzee (Pan troglodytes) care: a self-medication paradigm
